Using a peptide (p5RHH)-based nucleic acid delivery platform, siRNA targeting both NF-κB p65 and p100 was locally delivered to ATLL tumors, resulting in reduced mRNA and protein expression. This evidence concerns the gene NFKB1 and adult T-cell leukemia/lymphoma.